Accendra Health (ACH) Asset Writedowns and Impairment (2009 - 2024)
Accendra Health (ACH) reported Asset Writedowns and Impairment of -$1.9 million for Q3 2024, down 550.85% year-over-year from $413000.0 in Q4 2023, and down 1402.1% quarter-over-quarter from $143000.0 in Q2 2024.
Accendra Health (ACH) Asset Writedowns and Impairment (2009 - 2024) Analysis & Trends
Accendra Health (ACH) has 16 years of Asset Writedowns and Impairment data on file, last reported at -$1.9 million in Q3 2024.
- Asset Writedowns and Impairment for Q3 2024 came in at -$1.9 million, down 550.85% year-over-year; the trailing twelve-month figure through Sep 2024 was -$2.5 million (changed 0.16% YoY), and the FY2023 annual result was -$1.4 million, down 142.65% from the prior year.
- Asset Writedowns and Impairment declined to -$1.9 million in Q3 2024 per ACH's latest filing, from $143000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $8.5 million in Q1 2021 and troughed at -$2.0 million in Q4 2022.
- A 5-year average of $1.5 million and a median of $777000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 137.73% in 2024 and fell as far as 550.85% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $1.7 million in 2020, then advanced by 10.47% to $1.9 million in 2021, then slumped by 204.56% to -$2.0 million in 2022, then jumped by 53.04% to -$927000.0 in 2023, then plunged by 100.86% to -$1.9 million in 2024.
- Business Quant data shows ACH's Asset Writedowns and Impairment at -$1.9 million in Q3 2024, $143000.0 in Q2 2024, and $181000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -1.86 Mn |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 143,000.00 |
| Mar 31, 2024 | 181,000.00 |
| Mar 31, 2024 | 181,000.00 |
| Dec 31, 2023 | -927,000.00 |
| Dec 31, 2023 | -927,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Jun 30, 2023 | -379,000.00 |
| Jun 30, 2023 | -379,000.00 |
| Mar 31, 2023 | -521,000.00 |
| Mar 31, 2023 | -521,000.00 |
| Dec 31, 2022 | -1.97 Mn |
| Dec 31, 2022 | -1.97 Mn |
| Sep 30, 2022 | 777,000.00 |
| Sep 30, 2022 | 777,000.00 |
| Jun 30, 2022 | -1.12 Mn |
| Jun 30, 2022 | -1.12 Mn |